This map shows the geographic impact of B Vergmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Vergmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Vergmann more than expected).
This network shows the impact of papers produced by B Vergmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Vergmann. The network helps show where B Vergmann may publish in the future.
Co-authorship network of co-authors of B Vergmann
This figure shows the co-authorship network connecting the top 25 collaborators of B Vergmann.
A scholar is included among the top collaborators of B Vergmann based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with B Vergmann. B Vergmann is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Vergmann, B, et al.. (1984). [Resistant strains of Mycobacterium tuberculosis in the Gizan Area, Saudi Arabia].. PubMed. 146(51). 4024–6.3 indexed citations
4.
Vergmann, B, et al.. (1984). A prospective study of lung disease caused by Mycobacterium avium/Mycobacterium intracellulare.. PubMed. 65(6). 411–8.4 indexed citations
5.
Engbæk, H. C., et al.. (1982). Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.. PubMed. 63(2). 84–93.2 indexed citations
6.
Engbæk, H. C., B Vergmann, & Michael Weis Bentzon. (1981). Lung disease caused by Mycobacterium avium/Mycobacterium intracellulare. An analysis of Danish patients during the period 1962-1976.. PubMed. 62(2). 72–83.17 indexed citations
7.
Vergmann, B, et al.. (1981). [Cervical lymphadenitis in children cause by atypical mycobacteria and Mycobacterium avium].. PubMed. 143(43). 2787–91.3 indexed citations
8.
Vergmann, B, et al.. (1980). [Cutaneous infection with Mycobacterium marinum].. PubMed. 142(29). 1880–2.1 indexed citations
Engbæk, H. C., B Vergmann, & K. Bunch‐Christensen. (1977). Pulmonary tuberculosis due to BCG in a technician employed in a BCG laboratory.. PubMed. 55(4). 517–20.3 indexed citations
Vergmann, B, et al.. (1973). Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin.. PubMed. 54(2). 83–91.4 indexed citations
14.
Marks, J., Peter Jenkins, G. S. Kilpatrick, H. C. Engbæk, & B Vergmann. (1971). Pulmonary tuberculosis due to B.C.G.. BMJ. 3(5768). 229–230.19 indexed citations
15.
Engbæk, H. C. & B Vergmann. (1970). Rifampicin in the treatment of drug-resistant tuberculosis. A report on 13 patients with pulmonary and one patient with renal disease.. PubMed. 51(1). 11–27.3 indexed citations
16.
Engbæk, H. C., B Vergmann, & I. Baess. (1970). NON‐PHOTOCHROMOGENIC MYCOBACTERIA SEROTYPE DAVIS. Acta Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology. 78B(5). 619–631.11 indexed citations
17.
Engbæk, H. C., B Vergmann, I. Baess, & Michael Weis Bentzon. (1968). MYCOBACTERIUM AVIUM. Acta Pathologica Microbiologica Scandinavica. 72(2). 295–312.8 indexed citations
18.
Engbæk, H. C., B Vergmann, I. Baess, & Michael Weis Bentzon. (1968). MYCOBACTERIUM AVIUM. Acta Pathologica Microbiologica Scandinavica. 72(2). 277–294.20 indexed citations
19.
Engbæk, H. C., B Vergmann, I. Baess, & Drake W. Will. (1967). M. XENOPEI. Acta Pathologica Microbiologica Scandinavica. 69(4). 576–594.40 indexed citations
20.
Helms, Thomas M., et al.. (1967). [Tuberculosis in post-mortem material. Cases not diagnosed clinically].. PubMed. 129(50). 1673–7.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.